-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Amphastar Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
- Amphastar Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $5.6M, a 20.5% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $23.4M, a 17.2% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $20.2M, a 13.3% increase from 2022.
- Amphastar Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $17.9M, a 4.43% decline from 2021.
- Amphastar Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $18.7M, a 8.84% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)